Use of CpG oligodeoxynucleotides as immune adjuvants

Immunological Reviews
Dennis M KlinmanDaniela Verthelyi

Abstract

Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs directly stimulate human B cells and plasmacytoid dendritic cells (pDCs), thereby promoting the production of T helper 1 (Th1) and pro-inflammatory cytokines and the maturation/activation of professional antigen-presenting cells. These activities enable CpG ODNs to act as immune adjuvants, accelerating and boosting antigen-specific immune responses by 5-500-fold. These effects are optimized by maintaining close physical contact between the CpG DNA and the immunogen. Animal challenge models establish that protective immunity can be accelerated and magnified by coadministering CpG DNA with vaccines. Ongoing clinical studies indicate that CpG ODNs are safe and well tolerated when administered as adjuvants to humans, and in some cases, they increase vaccine-induced immune responses.

References

Mar 23, 1990·Science·J A WolffP L Felgner
Dec 1, 1990·Immunological Reviews·A D SteinbergD M Klinman
Jan 1, 1967·Advances in Immunology·J Sterzl, A M Silverstein
Jan 1, 1981·Progress in Nucleic Acid Research and Molecular Biology·A Razin, J Friedman
Apr 6, 1995·Nature·A M KriegD M Klinman
Mar 1, 1995·The Journal of Clinical Investigation·G S GilkesonD S Pisetsky
Oct 1, 1993·The Pediatric Infectious Disease Journal·E P DiamantV B Peters
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·M SedegahS L Hoffman
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·L R CardonS Karlin
Sep 1, 1993·Clinical Immunology and Immunopathology·G S GilkesonD S Pisetsky
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B WangD B Weiner
Nov 1, 1995·Journal of Clinical Immunology·A M Krieg
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·D M KlinmanA M Krieg
Sep 1, 1996·The Journal of Laboratory and Clinical Medicine·R F BrandaJ J McCormack
Dec 15, 1996·The Journal of Clinical Investigation·G MorD M Klinman
Feb 10, 1997·Human Gene Therapy·G MorD M Klinman
Mar 27, 1997·Nature·T SparwasserH Wagner
Dec 31, 1997·The Journal of Experimental Medicine·R S ChuC V Harding
Nov 18, 1997·Cell·R Medzhitov, C A Janeway
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·G J WeinerA M Krieg
Jan 1, 1997·Springer Seminars in Immunopathology·D M KlinmanJ Conover
Feb 17, 1998·European Journal of Immunology·G B LipfordH Wagner
May 21, 1998·Antisense & Nucleic Acid Drug Development·D M Klinman
Sep 22, 1998·Antisense & Nucleic Acid Drug Development·R WeeratnaH L Davis
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·A M KriegH L Davis
Nov 25, 1998·Cellular Immunology·A A HornerE Raz
Dec 22, 1998·The Journal of Experimental Medicine·S SunJ Sprent
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·C L Brazolot MillanH L Davis
Mar 17, 1999·Vaccine·D M KlinmanJ Conover
Jul 10, 1999·Advances in Immunology·H Wagner

❮ Previous
Next ❯

Citations

Sep 9, 2010·Cancer Immunology, Immunotherapy : CII·Julia PinkhasovPinku Mukherjee
Mar 3, 2007·Digestive Diseases and Sciences·Gary L DavisGyongyi Szabo
Mar 30, 2010·Fish Physiology and Biochemistry·Christopher Marlowe A CaipangViswanath Kiron
Oct 22, 2013·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Shu-Jie LiaoDing Ma
Sep 18, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Javier Briones
Jun 14, 2005·Current Opinion in Immunology·Andreas Wack, Rino Rappuoli
May 28, 2013·Materials Science & Engineering. C, Materials for Biological Applications·Song ChenNobutaka Hanagata
Nov 16, 2011·Immunology and Cell Biology·Romina P RanocchiaMaría C Pistoresi-Palencia
May 3, 2005·Nature Reviews. Drug Discovery·Mads Hald AndersenPer thor Straten
May 24, 2006·DNA and Cell Biology·Xochitl Cortez-GonzalezMaurizio Zanetti
Jun 24, 2005·Nucleic Acids Research·Andrzej GrajkowskiSerge L Beaucage
Jul 11, 2007·Current Opinion in Otolaryngology & Head and Neck Surgery·Deidra A Blanks
May 1, 2012·TheScientificWorldJournal·Marisa RossoMichael Berger
Mar 24, 2012·Clinical and Vaccine Immunology : CVI·Apichaya PuangpetchSurasakdi Wongratanacheewin
Jan 1, 2010·Annual Review of Chemical and Biomolecular Engineering·Pankaj Karande, Samir Mitragotri
Jan 10, 2012·Journal of Translational Medicine·Maria Luisa ViscianoLuigi Buonaguro
Apr 21, 2005·Avian Diseases·Rami A Dalloul, Hyun S Lillehoj
Nov 28, 2013·American Journal of Veterinary Research·Robert J Kemppainen
Mar 28, 2009·International Journal of Molecular Sciences·Mary E Christopher, Jonathan P Wong
Dec 7, 2013·Nature Medicine·Steven G ReedChristopher B Fox
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Joseph M ThompsonRobert E Johnston
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Grazia GalliSergio Abrignani
Nov 26, 2015·Microbes and Infection·Elis Araujo MoraisAlfredo Miranda de Goes
Oct 7, 2009·Expert Review of Vaccines·Franco Maria BuonaguroLuigi Buonaguro
Jul 20, 2005·Expert Review of Vaccines·Maxim PavlenkoPavel Pisa
Mar 7, 2007·Expert Review of Anticancer Therapy·Anita SchmittMichael Schmitt
May 4, 2012·Expert Review of Vaccines·Veronica L Fowler, Paul V Barnett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.